Cannabis Use Disorder Treatment Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview:

The Chitosan Oligosaccharides and Glucosamine Market is projected to grow from USD 2,402.25 million in 2024 to an estimated USD 4,965.13 million by 2032, at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2032.

Key drivers for the market include the increasing consumer demand for natural and functional ingredients in dietary supplements, alongside growing awareness of joint health, especially among aging populations. Chitosan oligosaccharides, derived from chitosan, are widely used for their benefits in weight management, cholesterol reduction, and gut health, driving their demand in the nutraceutical and food industries. Similarly, glucosamine, commonly used to support joint health and manage osteoarthritis symptoms, is experiencing growing adoption in the wellness sector. The rising prevalence of chronic joint conditions and the shift towards preventive healthcare further contribute to market growth. The rise of e-commerce platforms and online health stores is also making these products more accessible to a broader consumer base. Additionally, the expanding geriatric population and increasing healthcare expenditures globally are creating significant opportunities for market expansion. Advancements in biotechnology are expected to enhance the production processes for chitosan oligosaccharides and glucosamine, lowering costs and improving product offerings.

Market Drivers:

Growing Awareness of Joint Health and Osteoarthritis:

As the global population ages, the prevalence of joint-related conditions, such as osteoarthritis (OA), is expected to rise, driving the demand for glucosamine and chitosan oligosaccharides. The aging demographic is particularly susceptible to joint diseases like osteoarthritis, which is anticipated to become one of the leading causes of disability worldwide. According to the Centers for Disease Control and Prevention (CDC), about 30% of U.S. adults over the age of 65 are diagnosed with osteoarthritis, fueling the demand for joint health supplements. In Japan, where the population is rapidly aging, the market for glucosamine supplements has seen significant growth. A study by the Japanese Society of Clinical Rheumatology (JSCR) found that 22% of people aged 65 and above use glucosamine supplements to manage joint pain. The market for joint health products is also expanding in emerging economies like China and India due to rising healthcare awareness and growing disposable incomes.

Market Challenges:

Supply Chain and Production Cost Challenges:

A significant challenge in the Chitosan Oligosaccharides and Glucosamine Market is the high production costs associated with sourcing raw materials and manufacturing the supplements. Chitosan, derived from shellfish, and glucosamine require complex extraction processes, which increase production costs, especially when ensuring high purity and bioavailability of the final product. The reliance on specific raw materials also makes the supply chain vulnerable to fluctuations in raw material availability, such as chitin, which is harvested from crustacean shells. As a result, manufacturers may face pressure to maintain cost-efficiency while ensuring product sustainability and quality. For glucosamine production, costs are often impacted by the need for high-quality ingredients that meet stringent regulatory standards. Smaller manufacturers or new entrants may struggle to compete with established players who have the resources to invest in advanced manufacturing technologies and efficient supply chain management. These challenges are particularly pronounced in emerging markets where regulatory frameworks may not be well-established, further complicating sourcing and production. Companies will need to innovate in manufacturing processes, such as using biotechnology to improve yield and reduce costs, while navigating raw material sourcing and sustainability complexities.

Segmentations:

By Source:

Shrimp

Crab

Krill

Others

By Form:

Powder

Liquid

By Application:

Food & Beverages

Dietary Supplements

Pharmaceuticals

Cosmetics & Personal Care

By Region:

North America: United States, Canada, Mexico

Europe: United Kingdom, Germany, France, Italy, Spain

Asia Pacific: China, India, Japan, South Korea, Australia

Latin America: Brazil, Argentina, Chile

Middle East & Africa: South Africa, UAE, Saudi Arabia, Egypt

Key Player Analysis:

Primex ehf

Advanced Biopolymers AS

Golden-Shell Pharmaceutical Co., Ltd.

T.C. Bio Corporation

Panvo Organics Pvt Ltd

Qingdao Fraken International Trading Co., Ltd.

Yantai Shuangta Food Co., Ltd.

Amicogen Inc.

Koyo Chemical Co., Ltd.

Haidebei Marine Bioengineering Co., Ltd.

Zhejiang Golden-Shell Pharmaceutical Co., Ltd.

Qingdao BZ-Oligo Biotech Co., Ltd.